Please find attached herewith the relevant disclosure under Regulation 30.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Citichem India Limited has received shareholder approval at an Extraordinary General Meeting held on December 15, 2025, to issue up to 47,00,000 convertible warrants on a preferential basis. Each warrant, priced at Rs. 29, is convertible into one equity share of Rs. 10 face value, with the total issue size aggregating to approximately Rs. 13.63 crores. The warrants are proposed to be allotted to three identified individuals, including Managing Director Arif Esmail Merchant and two other persons. The issuance will be carried out under SEBI ICDR Regulations and is subject to necessary regulatory and statutory approvals.
The preferential warrant issue represents a potential equity dilution of up to Rs. 13.63 crores once converted. Participation by the Managing Director signals insider confidence, though existing shareholders should watch for dilution when warrants are eventually exercised.